Research ArticleOMERACT 9: International Consensus Conference on Outcome Measures in Rheumatology, Kananaskis Village, Alberta, Canada, May 27–31, 2008
Reappraisal of OMERACT 8 Draft Validation Criteria for a Soluble Biomarker Reflecting Structural Damage Endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis: The OMERACT 9 v2 Criteria
WALTER P. MAKSYMOWYCH, ROBERT LANDEWÉ, PAUL-PETER TAK, CHRISTOPHER J. RITCHLIN, MIKKEL ØSTERGAARD, PHILIP J. MEASE, HANI EL-GABALAWY, PATRICK GARNERO, DAFNA D. GLADMAN, OLIVER FITZGERALD, DANIEL ALETAHA, VIVIEN P. BYKERK, JOAN M. BATHON, SILJE W. SYVERSEN, MAARTEN BOERS, PIET GEUSENS, ROBERT D. INMAN, VIRGINIA B. KRAUS, TORE K. KVIEN, WILLIAM J. TAYLOR, GEORGE A. WELLS and DÉSIRÉE van der HEIJDE
The Journal of Rheumatology August 2009, 36 (8) 1785-1791; DOI: https://doi.org/10.3899/jrheum.090346
WALTER P. MAKSYMOWYCH
ROBERT LANDEWÉ
PAUL-PETER TAK
CHRISTOPHER J. RITCHLIN
MIKKEL ØSTERGAARD
PHILIP J. MEASE
HANI EL-GABALAWY
PATRICK GARNERO
DAFNA D. GLADMAN
OLIVER FITZGERALD
DANIEL ALETAHA
VIVIEN P. BYKERK
JOAN M. BATHON
SILJE W. SYVERSEN
MAARTEN BOERS
PIET GEUSENS
ROBERT D. INMAN
VIRGINIA B. KRAUS
TORE K. KVIEN
WILLIAM J. TAYLOR
GEORGE A. WELLS
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 36, Issue 8
1 Aug 2009
Reappraisal of OMERACT 8 Draft Validation Criteria for a Soluble Biomarker Reflecting Structural Damage Endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis: The OMERACT 9 v2 Criteria
WALTER P. MAKSYMOWYCH, ROBERT LANDEWÉ, PAUL-PETER TAK, CHRISTOPHER J. RITCHLIN, MIKKEL ØSTERGAARD, PHILIP J. MEASE, HANI EL-GABALAWY, PATRICK GARNERO, DAFNA D. GLADMAN, OLIVER FITZGERALD, DANIEL ALETAHA, VIVIEN P. BYKERK, JOAN M. BATHON, SILJE W. SYVERSEN, MAARTEN BOERS, PIET GEUSENS, ROBERT D. INMAN, VIRGINIA B. KRAUS, TORE K. KVIEN, WILLIAM J. TAYLOR, GEORGE A. WELLS, DÉSIRÉE van der HEIJDE
The Journal of Rheumatology Aug 2009, 36 (8) 1785-1791; DOI: 10.3899/jrheum.090346
Reappraisal of OMERACT 8 Draft Validation Criteria for a Soluble Biomarker Reflecting Structural Damage Endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis: The OMERACT 9 v2 Criteria
WALTER P. MAKSYMOWYCH, ROBERT LANDEWÉ, PAUL-PETER TAK, CHRISTOPHER J. RITCHLIN, MIKKEL ØSTERGAARD, PHILIP J. MEASE, HANI EL-GABALAWY, PATRICK GARNERO, DAFNA D. GLADMAN, OLIVER FITZGERALD, DANIEL ALETAHA, VIVIEN P. BYKERK, JOAN M. BATHON, SILJE W. SYVERSEN, MAARTEN BOERS, PIET GEUSENS, ROBERT D. INMAN, VIRGINIA B. KRAUS, TORE K. KVIEN, WILLIAM J. TAYLOR, GEORGE A. WELLS, DÉSIRÉE van der HEIJDE
The Journal of Rheumatology Aug 2009, 36 (8) 1785-1791; DOI: 10.3899/jrheum.090346